3 terminated, 1 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 3, Completed 1 |
| Phase 2 | 2 | Terminated 2 |
Follow DCC-2036: new trials by email Literature Review of DCC-2036 trials Research Report on DCC-2036
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors Rebastinib, Carboplatin - Locally Advanced or Metastatic Solid Tumor | Phase 1 / Phase 2 | Terminated | Deciphera Pharmaceuticals, LLC | 70 | 2019-01-02 | 2024-12-27 |
| A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors Rebastinib, Paclitaxel - Locally Advanced or Metastatic Solid Tumor | Phase 1 / Phase 2 | Terminated | Deciphera Pharmaceuticals, LLC | 177 | 2018-10-25 | 2024-12-27 |
| Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer Rebastinib, Paclitaxel, Eribulin Mesylate - Breast Cancer, Breast Adenocarcinoma | Phase 1 | Terminated | Montefiore Medical Center | 28 | 2016-07-01 | 2022-04-04 |
| Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation) DCC-2036 - Chronic Myeloid Leukemia | Phase 1 | Completed | Deciphera Pharmaceuticals, LLC | 57 | 2009-03-01 | 2014-07-18 |
Breast Neoplasms (3) · Neoplasm Metastasis (3) · Ovarian Neoplasms (2) · Carcinosarcoma (1) · Endometrial Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Mesothelioma (1)
Deciphera Pharmaceuticals, LLC (3) · Montefiore Medical Center (1)
United States (4)
B. Douglas Smith, MD (1) · David Snyder, M.D. (1) · Ehab Atallah, MD (1) · H.Jean Khoury, MD (1) · Hedy P Smith, MD (1) · Javier Pinilla-Ibarz, MD,PhD (1) · Jesus D Anampa Mesias, M.D (1) · Jorge Cortes, MD (1) · Kapil Bhalla, MD (1) · Moshe Talpaz, MD (1) · Richard A Larson, MD (1)